Table 3.
Cohort study procedural characteristics
| References | Author | Defined Perioperative Anticoagulation Protocol | DOAC | Emergent (%) | Bridging (%) | Procedural Type (%) |
|---|---|---|---|---|---|---|
| 24 | Schulman | Yes | Dabigatran | 0 | 1.7 |
Endoscopy/Bronchoscopy (21.8) EPS/Ablation (14.6) Cardiac Catheterization (12.4) ICD/PPM (9.6) Joint Surgery (5.4) Abdominal Surgery (5.2) Biopsy (4.4) Ocular (3.9) Vascular (3.5) TURP/TURBT (3.1) Other (16.1) |
| 25 | Kosiuk | Yes | Dabigatran | 0 | 0 |
PPM (65.0) ICD (35.0) |
| 26 | Terekhov | No | Dabigatran | 0 | 0 | PPM (100.0) |
| 27 | Madan | No | Dabigatran | 0 | 0 |
PPM (55.3) ICD (44.7) |
DOAC, Direct Oral Anticoagulant; EPS, Electrophysiology Procedure; ICD, Implantable Cardioverter Defibrillator; PPM, Permanent Pacemaker; TURP, Transurethral Resection of the Prostate; TURBT, Transurethral Resection of Bladder Tumor.